Financials Scilex Holding Company

Equities

SCLX

US80880W1062

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2024-07-16 EDT 5-day change 1st Jan Change
1.96 USD +3.70% Intraday chart for Scilex Holding Company +8.89% -3.92%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 564 199.6 237.4 - -
Enterprise Value (EV) 1 564 199.6 237.4 237.4 237.4
P/E ratio -23.5 x -1.59 x -2.66 x -4.03 x -3.88 x
Yield - - - - -
Capitalization / Revenue - 4.27 x 3.95 x 2.66 x 2.68 x
EV / Revenue - 4.27 x 3.95 x 2.66 x 2.68 x
EV / EBITDA - - - - -
EV / FCF - -9.62 x -1.93 x -2.14 x -3.54 x
FCF Yield - -10.4% -51.9% -46.7% -28.2%
Price to Book - - - - -
Nbr of stocks (in thousands) 141,349 97,837 121,121 - -
Reference price 2 3.990 2.040 1.960 1.960 1.960
Announcement Date 3/7/23 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 46.74 60.09 89.17 88.63
EBITDA - - - - -
EBIT 1 - -105.4 -91.05 -88.8 -84.29
Operating Margin - -225.55% -151.52% -99.59% -95.11%
Earnings before Tax (EBT) 1 - -114.3 -102.1 -95.77 -87.42
Net income 1 -23.36 -114.3 -102.1 -95.77 -90.57
Net margin - -244.59% -169.82% -107.4% -102.2%
EPS 2 -0.1700 -1.280 -0.7367 -0.4867 -0.5050
Free Cash Flow 1 - -20.74 -123.2 -110.8 -67
FCF margin - -44.36% -205.01% -124.25% -75.6%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/7/23 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - 10.12 13.46 10.88 13.17 16.03 20.01 20 21.7
EBITDA - - - - - - - - -
EBIT 1 - -38.8 -18.34 -19.48 -26.42 -25.25 -25.78 - -
Operating Margin - -383.56% -136.23% -178.96% -200.58% -157.53% -128.8% - -
Earnings before Tax (EBT) 1 - -35.53 -21.39 -24.38 -30.08 -28.58 -29.04 - -
Net income 1 -26.65 -35.53 -21.39 -24.38 -30.08 -28.58 -29.04 - -
Net margin - -351.18% -158.87% -223.97% -228.39% -178.29% -145.1% - -
EPS 2 -0.1900 -0.6300 -0.2500 -0.2400 -0.1967 -0.1733 -0.1700 -0.1500 -0.1350
Dividend per Share - - - - - - - - -
Announcement Date 8/11/23 11/14/23 3/12/24 5/13/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - -20.7 -123 -111 -67
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - 0.33 - - -
Capex / Sales - 0.71% - - -
Announcement Date 3/7/23 3/12/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.96 USD
Average target price
5.333 USD
Spread / Average Target
+172.11%
Consensus
  1. Stock Market
  2. Equities
  3. SCLX Stock
  4. Financials Scilex Holding Company